Skip to main content

Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations

Written by Customer Service on . Posted in Public Companies.

WOBURN, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the hiring of Darren Greenfield to serve as the Company’s Senior Director of Seed Operations. In this newly created position, Mr. Greenfield will be responsible for Camelina seed scale up and commercial contract production. He brings over 25 years of experience with major agriculture companies managing the development and commercial production of proprietary canola plant varieties. He also brings experience with identity preserved supply chains for specialty products based on his work at Dow Agrosciences with high oleic canola oil. He joins Yield10 from BASF Canada, Inc.

“We are delighted to welcome Darren to our team and will rely on his significant experience and successful track record leading seed operations and establishing production contracts with growers in our commercial launch geography,” said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10. “We look forward to his contributions as we scale up our current lead Camelina varieties and progress improved varieties including herbicide tolerant lines in our development and commercialization pipeline. Our primary goal is to establish the Camelina seed supply chain and address the growing global demand for biofuel feedstock oils and protein meal. We expect that the development and commercialization of these seed products will be followed by the launch of our EPA/DHA omega-3 nutritional oil and PHA bioplastics Camelina plant varieties as our proprietary traits are brought online.”

“The team at Yield10 has done impressive work to date in establishing a differentiated Camelina seed trait and product pipeline as well as in developing spring and winter lines of Elite Camelina with good seed yield and oil content as a basis for transitioning to early commercial development,” said Mr. Greenfield. “I look forward to introducing growers to Camelina and successfully driving adoption of the crop in the U.S. and Canada.”

Mr. Greenfield has extensive experience contracting and working with growers in Canada, the U.S. and South America as well as building supply chain and inventory operations. From January to December 2021, he was senior certified canola production agronomist at BASF Canada Inc. From 2018 to 2020, he was seed production manager and a member of the senior executive team at Cibus Canada, ULC where he managed grower contracting, seed production, packaging and shipping for canola operations. From 2010 to 2018, Mr. Greenfield held various positions at Dow Agrosciences Canada, Inc where he was most recently canola operations leader for Nexera™, a canola trait, where he directed all aspects of canola seed operations. He was also a member of the Canola and Business Leadership teams during his tenure at Dow Agrosciences. Mr. Greenfield is a Professional Agrologist and a Certified Crop Advisor.

About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina to produce feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

(YTEN-G)

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, expectations related to seed scale up, establishment of a Camelina seed supply chain, launch of a Camelina seed operation and business, product development and future licensing arrangements, as well as the overall progress of Yield10 Bioscience, Inc., constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience’s filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.